Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Surufatinib in advanced pancreatic neuroendocrine tumours (SANET-p): a randomised, double-blind, placebo-controlled, phase 3 study
PaperCitations, authors & open-access status
Surufatinib in advanced pancreatic neuroendocrine tumours (SANET-p): a randomised, double-blind, placebo-controlled, phase 3 study is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 194 citations, 2020 year and closed oa status.
194
Citations
2020
Year
closed
OA Status